Translational Session
Biomarker Studies in Lupus Nephritis: A New Opportunity for Precision Medicine
November 02, 2023 | 10:30 AM - 12:30 PM
Location: Room 103, Pennsylvania Convention Center
Session Description
Lupus nephritis (LN) is a major cause of morbidity and mortality among patients with systemic lupus erythematosus. In this session, promising biomarkers that may pave the way toward an improved management of patients with LN are discussed.
Learning Objective(s)
- Discuss the challenges of applying novel biomarkers in a clinical setting
- Specify the structural biomarkers (pathology) currently used and areas of improvement
- Explain how biomarkers are used to guide targeted therapies for LN
- Describe the application of single-cell sequencing in biomarker development for LN
Learning Pathway(s)
- Pathology
- Glomerular Diseases
Moderators
Presentations
- Overview and Clinical Utility of Biomarkers in Lupus Nephritis
10:30 AM - 11:00 AM
- Application of Single-Cell RNA Sequencing in Molecular Profiling of Lupus Nephritis
11:00 AM - 11:30 AM
- Renal Pathologic Correlates of Biomarker and Molecular Studies
11:30 AM - 12:00 PM
- Current Biologic-Targeted Therapies in Lupus Nephritis
12:00 PM - 12:30 PM